Search results

News 11

View all

• Press Release
  
  Modeling a devastating childhood disease on a chip
  June 23, 2022
• Research Spotlights
  
  Course correction on the path to liquid brain biopsies
  June 21, 2021
• Press Release
  
  Repurposing approved drugs for COVID-19 at an accelerated pace
  June 16, 2020

Multimedia 4

• 

  Video/Animation
  OMNIVAX: Infection Vaccine Platform
  This video explains how OMNIVAX – an immuno-material-based vaccine technology can be used to rapidly create injectable vaccines against diverse viral and bacterial pathogens, and how the platform is used by the team to develop a vaccine against recurring urinary tract infections (UTIs) in their lead human application. Credit: Wyss Institute at Harvard University.

• 

  Video/Animation
  Beating Back the Coronavirus: FDA-Approved Drug Repurposing Pipeline
  With the goal of rapidly repurposing FDA-approved drugs to treat COVID-19, the Wyss Institute is collaborating with the Frieman Lab at the University of Maryland Medical School and the tenOever Lab at the Icahn School of Medicine at Mount Sinai to establish a multidisciplinary pipeline that can rapidly predict, test, and validate potential treatments. Credit:...

• 

  Video/Animation
  Tiny 3D-Printed Battery
  In this video, a 3D-printer nozzle narrower than a human hair lays down a specially formulated “ink” layer by layer to build a microbattery’s anode from the ground up. Unlike ink in an office inkjet printer, which comes out as droplets of liquid and wets a piece of paper, these 3D-printer inks are specially formulated...

• 

  Video/Animation
  SLIPS
  ‘SLIPS’ technology, inspired by the slippery pitcher plant that repels almost every type of liquid and solid, is a unique approach to coating industrial and medical surfaces that is based on nano/microstructured porous material infused with a lubricating fluid. By locking in water and other fluids, SLIPS technology creates slick, exceptionally repellent and robust self-cleaning...